Hydroxyzine Injectable solution (IM)

Form: Injectable solution (IM)

Strength: 25 mg/mL, 50 mg/mL

Reference Brands: US: Vistaril®, , Atarax®; EU: Atarax®, Hydroxyzine Mylan®, Ucerax®

Category: Antipsychotropic Drugs

Hydroxyzine Injectable Solution (IM) is FDA-approved in the USA for short-term use in anxiety, preoperative sedation, and allergic conditions. Its use is limited to intramuscular administration only, as intravenous or subcutaneous routes are contraindicated due to tissue irritation risks. In the European Union, its availability varies by country, often regulated under national authorization procedures, with labeling focused on CNS depression, QT prolongation, and age-specific dosing precautions. Pharmacovigilance measures, including Risk Management Plans (RMPs), are enforced. Hydroxyzine IM is valued for its rapid onset in acute care. Explore more forms at Pharmatradz.com.